https://sciex.com/content/SCIEX/na/us/en


Why Microflow HILIC Chromatography for Targeted Metabolomics Applications?

Aug 10, 2017 | Blogs, Life Science Research, Metabolomics | 0 comments

I recently had the opportunity to catch up with Baljit Ubhi to discuss the top questions you’re asking in regards to using Microflow HILIIC Chromatography for Targeted Metabolomics. Here’s what Bal said:

Why is analyzing polar metabolites so challenging?

Many of the metabolites of interest in the study of metabolomics are extremely polar and therefore often unable to be analyzed through traditional coupling of reversed phase (RP) chromatography and mass spectrometry. Also to detect and quantify key metabolites from pathways of biochemical importance, samples must be run on both reversed phase and normal phase, in negative and positive ion modes requiring a total of four injections.

How does this workflow address those challenges?

We have implemented hydrophilic chromatography (HILIC) with microflow and mass spectrometry to develop a method for screening over 300 polar metabolites. HILIC allows separation by partitioning of analytes between an aqueous enriched layer of a polar stationary phase. HILIC conditions typically use high organic, with a moderate amount of a salt (i.e. 20-100mM ammonium formate or acetate, pH 4.4 or 5.5. respectively). This method deviates by having 20 mM ammonium hydroxide in both mobile phases to provide constant pH of 9.0 during the chromatographic separation. The high pH deprotonates the stationary phase and allows for better selectivity of the polar metabolites. The method is multiple reaction monitoring (MRM) with positive/negative polarity switching allowing the collection of these key metabolites in a single injection!

What is unique about the sample prep and chromatography?

While microflow has become increasingly popular for many applications, microflow for metabolomics has not been readily employed because the typically used (aqueous) sample solvent does not allow for injecting larger volumes of samples without sacrificing chromatographic resolution. However, by simply reconstituting the sample in an organic solvent (95% acetonitrile, pH 9), we were able to inject up to 5 µL onto the microLC column, while maintaining excellent peak shape.

How does microflow LC compare to traditional high flow LC approaches for metabolomics? What makes it better?

The microflow Luna-NH2 HILIC chromatography provides excellent chromatographic separation of polar, hydrophilic metabolites. The cross-linked aminopropyl phase gives a slightly different selectivity than the traditional amide phase; it gives higher coverage of the metabolome when compared to the amide functionality. This allows for improved sensitivity with signal-to-noise (S/N) improvement of up to 60X and up to 50% higher coverage of the metabolome than traditional analytical approaches (see table above).

Questions and answers to help improve your mycotoxin analysis

During a recent webinar I shared method details for mycotoxin analysis on the SCIEX 7500 system. In this blog i will share the Q&A for the submitted questions that we did not have chance to answer during the live webinar.

A 2-fold revolution: MS approaches for the bioanalysis of oligonucleotide therapeutics

In 1998, the US Food and Drug Administration (FDA) approved fomivirsen as the first therapeutic oligonucleotide therapeutic. This approval marked a revolution of mechanism of action discovered decades before finally coming to fruition. Since then, the landscape of chemical modifications of oligonucleotides, conjugations and formulations has evolved tremendously, contributing to improvements in stability, efficacy and safety. Today, more than a dozen antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) drugs are on the market, most of which are designated as orphan drugs for treating rare genetic diseases.

Is “right first time, every time” a pipedream for metabolite identification by LC-MS?

If we lived in an ideal world, it would be possible to unambiguously identify metabolites using a single analytical experiment. This analytical technique would need to be efficient and easily generate the information needed from a routine assay that is also robust, enabling confident decision-making during drug discovery.

Posted by

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial